跳至主要内容
临床试验/NCT05181514
NCT05181514已完成不适用

Impact of Plasma Lipids on β Cell Function and Insulin Sensitivity

Azienda Ospedaliero, Universitaria Pisana2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2019年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Glucose control

研究概览

简要总结

The investigators aim to evaluate whether and to what extent glucose tolerance, beta cell function, insulin clearance, and glucose metabolic fluxes change in response to an acute increase in plasma triglycerides during lipid infusion, independently of free fatty acid (FFA) levels, in nondiabetic subjects.

详细描述

Mild hypertriglyceridemia is associated with reduced glucose tolerance and increased risk of type 2 diabetes, independent of obesity, in both cross-sectional and prospective studies. It is unclear whether this association is direct or mediated by circulating lipid substrates of triglycerides (free fatty acids, or FFA) and which are the mechanisms involved.

To comprehensively examine the effects of mild acute hypertriglyceridemia on major glucose homeostatic mechanisms involved in diabetes progression, two dual-labeled oral glucose tolerance tests (OGTT) during 5-hour intravenous infusions of either 20% Intralipid or normal saline will be performed in healthy lean volunteers. Lipid-induced changes in glucose tolerance and insulin metabolism will be evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18-65 years
  • Body mass index (BMI) 18-35 kg/m2
  • both women and men

排除标准

  • chronic or acute diseases
  • any medications
  • pregnancy

结局指标

主要结局

Glucose control

时间窗: At the end of the 5-hour lipid infusion

Incremental area under the curve (AUC) of plasma glucose in response to the oral glucose tolerance test (OGTT)

Beta cell glucose sensitivity

时间窗: At the end of the 5-hour lipid infusion

Beta cell glucose sensitivity calculated by mathematical modeling of insulin secretion rate (ISR) and plasma glucose concentrations during the oral glucose tolerance test (OGTT)

Insulin clearance

时间窗: At the end of the 5-hour lipid infusion

Insulin clearance calculated as the ratio between insulin secretion rate (ISR) and plasma insulin levels

Rate of oral glucose appearance (RaO)

时间窗: At the end of the 5-hour lipid infusion

The rate of oral glucose appearance (RaO) will be assessed from the time course of the plasma tracer/tracee ratio of 6,6-\[2H2\]glucose and \[U-13C\]glucose

Endogenous glucose production (EGP)

时间窗: At the end of the 5-hour lipid infusion

The endogenous glucose production (EGP) will be assessed from the time course of the plasma tracer/tracee ratio of 6,6-\[2H2\]glucose and \[U-13C\]glucose

Insulin sensitivity

时间窗: At the end of the 5-hour lipid infusion

Insulin sensitivity estimated by an OGTT-derived surrogate index (Matsuda index)

Insulin secretion

时间窗: At the end of the 5-hour lipid infusion

Insulin secretion rate (ISR) estimated from C-peptide deconvolution at fasting and in response to the oral glucose tolerance test (OGTT)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea Natali

Full Professor

Azienda Ospedaliero, Universitaria Pisana

研究点 (2)

Loading locations...

相似试验